1. Editorial: the management of IBD during pregnancy and lactation – author's reply. Issue 10 (November 2014) Authors: Schulze, H.; Esters, P.; Dignass, A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 40:Issue 10(2014) Page Start: 1248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Identification of a novel HLA‐B null allele, HLA‐B*41:45N, by HLA typing of two related Caucasoid individuals. (4th July 2016) Authors: Todorova, K.; Zuber, K.; Arnold, R.; Schönemann, C.; Schulze, H. Journal: HLA Issue: Volume 88:Number 1/2(2016) Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Identification of the novel HLA‐A*11:192 allele by HLA typing of a Caucasian individual. Issue 5 (2nd October 2014) Authors: Todorova, K.; Zuber, K.; Neuwirt, P.; Arnold, R.; Schönemann, C.; Schulze, H. Journal: Tissue antigens Issue: Volume 84:Issue 5(2014) Page Start: 509 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Letter: a case supporting the use of rescue infliximab therapy for fulminant ulcerative colitis in pregnancy – authors' reply. Issue 3 (February 2015) Authors: Schulze, H.; Esters, P.; Dignass, A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 41:Issue 3(2015) Page Start: 326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Letter: leucocytapheresis as a nonpharmacologic treatment for patients with ulcerative colitis during pregnancy – authors' reply. Issue 2 (January 2015) Authors: Schulze, H.; Esters, P.; Dignass, A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 41:Issue 2(2015) Page Start: 235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Review article: the management of Crohn's disease and ulcerative colitis during pregnancy and lactation. Issue 9 (9th September 2014) Authors: Schulze, H.; Esters, P.; Dignass, A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 40:Issue 9(2014) Page Start: 991 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease – a prospective multicenter observational study. Issue 11 (7th October 2016) Authors: Stallmach, A.; Langbein, C.; Atreya, R.; Bruns, T.; Dignass, A.; Ende, K.; Hampe, J.; Hartmann, F.; Neurath, M. F.; Maul, J.; Preiss, J. C.; Schmelz, R.; Siegmund, B.; Schulze, H.; Teich, N.; von Arnim, U.; Baumgart, D. C.; Schmidt, C. Journal: Alimentary pharmacology & therapeutics Issue: Volume 44:Issue 11/12(2016) Page Start: 1199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease – a prospective multicenter observational study. Issue 11 (7th October 2016) Authors: Stallmach, A.; Langbein, C.; Atreya, R.; Bruns, T.; Dignass, A.; Ende, K.; Hampe, J.; Hartmann, F.; Neurath, M. F.; Maul, J.; Preiss, J. C.; Schmelz, R.; Siegmund, B.; Schulze, H.; Teich, N.; von Arnim, U.; Baumgart, D. C.; Schmidt, C. Journal: Alimentary pharmacology & therapeutics Issue: Volume 44:Issue 11/12(2016) Page Start: 1199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗